Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioAmber Inc. BIOAQ

BioAmber Inc is an industrial biotechnology company producing renewable chemicals. The company's proprietary technology platform combines industrial biotechnology and chemical catalysis to convert bio-based feedstocks into renewable chemicals that are cost-competitive replacements for petroleum-derived chemicals used in a wide variety of everyday products including plastics, resins, paints, food additives and personal care products. BioAmber produces bio-succinic acid at a facility in Sarnia, On


OTCPK:BIOAQ - Post by User

Comment by Mrtkr1on Mar 04, 2018 6:44am
296 Views
Post# 27657590

RE:RE:RE:Whats next

RE:RE:RE:Whats nextI agree with you that managment is beyond unprofessional for not providing timely updates. However, shares can easily be traded in the OTC markets. This is a fact. I have sold and bought myself and I live in Canada. I also think being removed from the TSX helped slow the panic. Not saying the panic is unnatural or unwarranted but I am saying investors always overreact. They overreact both on the upside and the downside. Removing Canadians has removed part of this overreaction. 

I think fundementaly, this stock was never worth $6 plus. Having said this, the stock is worth more then the current price and should trade at around $0.25 USD with ease. In fact, if you take the assets ($155.5mm) and subtract the liabilities ($48.7mm) you have a total of $107mm. Now assuming the company is too risky and is worth only 50% of the actual value you get a price of $53.5mm. There are less then 100mm shares fully diluted but let says we use an even bigger scale of 120mm shares. Take 53.5mm and divide by 120mm. You get a shares price of $0.445 USD or $0.57 CND.

Its worth noting that I have discounted the company by 50% and have diluted the value further by increasing the share count. Even when taking into consideration the incompetency of managment and/or their lack of transparency, Bioamber presents value for those with a strong stomach. That is not to say there is no risk but remember that this stock has been shorted heavily and even slight positive news will force shorts to cover. This will bring the share price closer to its “ACTUAL” price. It will happen quickly as those that are shorting in the OTC are professionals and have a clear idea of the true price of this stock. Make no mistake. Shorting in the OTC requires lots of capital and knowledge. Again this company is currently not worth $6 or anything near that but I think $0.50-$1.00 CND is within reality.

My suggestion for actual shareholders is to stop listening to the drama being spread by shorters, bashers, pumpers and dilutional investors. Place them on ignore. Flag them for abuse if then bash or pump excessively. Do the math yourself. Do your own DD. Crunch the numbers. Evaluate the risk. You will find my price target to be reasonable. If you decide to hang on, make shorting more difficult by following the steps outlined on the link below:

https://www.contracts-for-difference.com/Borrowing-lending-shares.html
<< Previous
Bullboard Posts
Next >>